Science Explorer Back to mapMap
Discussion
Institution · Boston Scientific (United States)

Most cited papers from Boston Scientific (United States)

Boston Scientific (United States)

What are the most cited papers from Boston Scientific (United States)?

The most cited paper from Boston Scientific (United States) is "Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease" (Patrick W.J.C. Serruys, Marie‐Claude Morice, A. Pieter Kappetein et al., 2009), with 4,377 citations. Next come "A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease" (2,753) and "Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial" (1,807).

Showing 50 of 60 papers. Every paper with more than 247 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease Patrick W.J.C. Serruys, Marie‐Claude Morice, A. Pieter Kappetein et al. · New England Journal of Medicine Open access 18 Feb 2009 4,377
2 A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease Gregg W. Stone, Stephen G. Ellis, David Alan Cox et al. · New England Journal of Medicine Open access 14 Jan 2004 2,753
3 Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Friedrich Wilhelm Mohr, Marie-Claude Morice, A. Pieter Kappetein et al. · The Lancet Feb 2013 1,807
4 5-Year Outcomes After Left Atrial Appendage Closure Vivek Yerrapu Reddy, Shephal K. Doshi, Saibal Kar et al. · Journal of the American College of Cardiology Open access 4 Nov 2017 1,028
5 Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation Vivek Yerrapu Reddy, Horst Sievert, Jonathan L. Halperin et al. · JAMA 16 Nov 2014 1,012
6 Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation Vivek Yerrapu Reddy, Edward P. Gerstenfeld, Andrea Natale et al. · New England Journal of Medicine 27 Aug 2023 947
7 TAXUS I Eberhard Grube, Sigmund Silber, Karl Eugen Hauptmann et al. · Circulation 7 Jan 2003 869
8 Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Vasim Farooq, David V. Klaveren, Ewout Willem Steyerberg et al. · The Lancet Feb 2013 842
9 Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease Gregg W. Stone, Stephen G. Ellis, Louis Cannon et al. · JAMA 13 Sep 2005 770
10 Assessment of the SYNTAX score in the Syntax study Patrick Serruys, Yoshinobu Onuma, Scot Garg et al. · EuroIntervention May 2009 650
11 Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial Marie-Claude Morice, Patrick W.J.C. Serruys, A. Pieter Kappetein et al. · Circulation 8 Jun 2010 644
12 A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Toby M. Freyman, Glenn M. Polin, Hashim E. Osman et al. · European Heart Journal Open access Mar 2006 616
13 Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial A. Pieter Kappetein, Ted E Feldman, Michael J. Mack et al. · European Heart Journal Open access 22 Jun 2011 564
14 Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study Riad Salem, Guy E. Johnson, Edward Kim et al. · Hepatology Open access 19 Mar 2021 555
15 Organizational Culture’s Influence on Creativity and Innovation: A Review of the Literature and Implications for Human Resource Development Laird D. McLean · Advances in Developing Human Resources 29 Mar 2005 553
16 Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry Lucas V.A. Boersma, Lucas V.A. Boersma, Boris Schmidt et al. · European Heart Journal Open access 27 Jan 2016 526
17 Efficacy and Safety of Surgical Decompression in Patients with Cervical Spondylotic Myelopathy Michael George Fehlings, Jefferson R. Wilson, Branko Kopjar et al. · Journal of Bone and Joint Surgery 18 Sep 2013 513
18 Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator Martin C. Burke, Michael Robert Gold, Bradley P. Knight et al. · Journal of the American College of Cardiology Open access Apr 2015 503
19 Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry Pier David Lambiase et al. · European Heart Journal Open access 26 Mar 2014 462
20 Device-Related Thrombus After Left Atrial Appendage Closure Srinivas Rao Dukkipati, Saibal Kar, David R. Holmes et al. · Circulation Open access 11 May 2018 454
21 Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial Lucas V.A. Boersma, Hueseyin Ince, Stephan Kische et al. · Heart Rhythm Open access Jun 2017 439
22 Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device Saibal Kar et al. · Circulation Open access 6 Apr 2021 421
23 A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases Brenda R. Motheral, John M. Brooks, Mary Ann Clark et al. · Value in Health Open access Mar 2003 417
24 Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017 Xurui Jin, Chanchal Chandramouli, Brooke Allocco et al. · Circulation Open access 17 Feb 2020 407
25 Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial† A. Pieter Kappetein, Stuart J. Head, Marie‐Claude Morice et al. · European Journal of Cardio-Thoracic Surgery Open access 14 Feb 2013 405
26 A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices JOHN P. BOEHMER, Ramesh Hariharan, Fausto Devecchi et al. · JACC Heart Failure Open access 28 Feb 2017 395
27 Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial Faiez M. Zannad, Gaetano Maria De Ferrari, Anton E. Tuinenburg et al. · European Heart Journal Open access 31 Aug 2014 381
28 Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions Georgios Christopoulos, David E. Kandzari, Robert W. Yeh et al. · JACC: Cardiovascular Interventions Open access 2016 366
29 Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial Stuart J. Head, Piroze Minoo Davierwala, Patrick W.J.C. Serruys et al. · European Heart Journal 21 May 2014 366
30 Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival David L. Hayes, JOHN P. BOEHMER, John Day et al. · Heart Rhythm 19 Apr 2011 349
31 The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy Michael Robert Gold, Ulrika Maria Birgersdotter-Green, G. André Ng et al. · European Heart Journal Open access 29 Aug 2011 347
32 The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase Andrew T.L. Ong, Patrick W.J.C. Serruys, Frederick W. Mohr et al. · American Heart Journal Jun 2006 340
33 Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation Sung-Han Yoon et al. · Journal of the American College of Cardiology Open access 27 Nov 2017 339
34 Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry Lucas V.A. Boersma, Craig Scott Barr, Reinoud E. Knops et al. · Journal of the American College of Cardiology Open access Aug 2017 331
35 Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement Samir Ramesh Kapadia et al. · New England Journal of Medicine Open access 17 Sep 2022 320
36 TAXUS III Trial Kengo Tanabe, Patrick W.J.C. Serruys, Eberhard Grube et al. · Circulation Open access 3 Feb 2003 320
37 Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos) Yang K. Chen, Mansour A. Parsi, Kenneth Frank Binmoeller et al. · Gastrointestinal Endoscopy 23 Jul 2011 318
38 Medical applications of poly(styrene-block-isobutylene-block-styrene) (“SIBS”) Leonard Pinchuk, Gregory John Wilson, James J. Barry et al. · Biomaterials 20 Nov 2007 316
39 Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty James Sapontis et al. · JACC: Cardiovascular Interventions Open access Aug 2017 315
40 EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry Boris Schmidt, Stefano Bordignon, Kars G.E.J. Neven et al. · EP Europace Open access 28 Jun 2023 308
41 Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma Michael E. Wechsler et al. · Journal of Allergy and Clinical Immunology Open access 30 Aug 2013 305
42 The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions Vasim Farooq et al. · Journal of the American College of Cardiology Open access 19 Dec 2012 302
43 A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial William A. Gray et al. · The Lancet 24 Sep 2018 300
44 Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia Jan van Ramshorst, Jeroen Joost Bax, Saskia L.M.A. Beeres et al. · JAMA 19 May 2009 300
45 Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITÉ artificial disc versus lumbar fusion: Five-year follow-up Richard D. Guyer, Paul C. McAfee, Robert Banco et al. · The Spine Journal 20 Sep 2008 293
46 Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery David Jonathan Cohen, Ben van Hout, Patrick W.J.C. Serruys et al. · New England Journal of Medicine Open access 16 Mar 2011 292
47 Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease Adrian Banning, Stephen Westaby, Marie‐Claude Morice et al. · Journal of the American College of Cardiology Open access 15 Jan 2010 292
48 Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology Lucas V.A. Boersma et al. · Circulation Arrhythmia and Electrophysiology Open access Apr 2019 288
49 Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months Douglas E. Drachman, Elazer Reuven Edelman, Philip A. Seifert et al. · Journal of the American College of Cardiology Open access Dec 2000 288
50 Machine Learning-Based Phenogrouping in Heart Failure to Identify Responders to Cardiac Resynchronization Therapy Maja Čikeš, Sergio Sanchez‐Martinez, Brian Lee Claggett et al. · European Journal of Heart Failure Open access 17 Oct 2018 287

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.